SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Solarius Capital Acquisition Corp.
Date: July 15, 2025 · CIK: 0002065948 · Accession: 0001185185-25-000777

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288078

Date
July 15, 2025
Author
Managing Director
Form
CORRESP
Company
Solarius Capital Acquisition Corp.

Letter

Re: Solarius Capital Acquisition Corp.

July 15, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333-288078

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as representative of the underwriters for the proposed public offering of units of Solarius Capital Acquisition Corp. (the “Company”) pursuant to the above-referenced Registration Statement, hereby joins in the request of the Company for acceleration of the effective date of the above-referenced Registration Statement so that it becomes effective at 4:30 p.m., Eastern time, on Tuesday, July 15, 2025, or as soon as possible thereafter.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act, the undersigned advises you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced proposed offering.

[ Signature Page Follows ]

Very truly yours,
STIFEL, NICOLAUS & COMPANY, INCORPORATED

Show Raw Text
CORRESP
 1
 filename1.htm

 July 15, 2025

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 Office of Life Sciences

 100 F Street, N.E.

 Washington, D.C. 20549

 Re:
 Solarius Capital Acquisition Corp.

 Registration Statement on Form S-1

 File No. 333-288078

 Ladies and Gentlemen:

 In accordance with Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as representative of the underwriters for
the proposed public offering of units of Solarius Capital Acquisition Corp. (the “Company”) pursuant to the above-referenced
Registration Statement, hereby joins in the request of the Company for acceleration of the effective date of the above-referenced Registration
Statement so that it becomes effective at 4:30 p.m., Eastern time, on Tuesday, July 15, 2025, or as soon as possible thereafter.

 Pursuant to Rule 460 of the General
Rules and Regulations under the Securities Act, the undersigned advises you that there will be distributed to each underwriter or dealer,
who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus
as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 The undersigned advises that it
has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in
connection with the above-referenced proposed offering.

 [ Signature Page Follows ]

 Very truly yours,

 STIFEL, NICOLAUS & COMPANY, INCORPORATED

 By:
 /s/ Alysa Craig

 Name:
 Alysa Craig

 Title:
 Managing Director

 [ Signature Page to SEC Letter from Underwriters
Requesting Acceleration of Effectiveness ]